Status of work in February
In February, AOTMiT begins work on orders from the Minister of Health:
- Embavi (apixaban) for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation and at least one risk factor
- Apixaban (apixabanum) for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with at least one risk factor
- Nubeqa (darolutamidum) for the treatment of patients with prostate cancer
The listed order is available on the AOTMiT Public Information Bulletin.